Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women
This study is enrolling participants by invitation only.
Sponsor:
Yonsei University
Information provided by:
Yonsei University
ClinicalTrials.gov Identifier:
NCT00900653
First received: May 12, 2009
Last updated: May 29, 2009
Last verified: May 2009
| Tracking Information | |
|---|---|
| First Received Date ICMJE | May 12, 2009 |
| Last Updated Date | May 29, 2009 |
| Start Date ICMJE | May 2009 |
| Estimated Primary Completion Date | May 2010 (final data collection date for primary outcome measure) |
| Current Primary Outcome Measures ICMJE |
Incidence of urinary tract infection [ Time Frame: 6 months ] [ Designated as safety issue: No ] |
| Original Primary Outcome Measures ICMJE | Same as current |
| Change History | Complete list of historical versions of study NCT00900653 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE |
|
| Original Secondary Outcome Measures ICMJE | Same as current |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women |
| Official Title ICMJE | Low Dose Estriol With Lactobacilli (Gynoflor) Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized, Open, Parallel-Group Study |
| Brief Summary | Recurrent urinary tract infections (UTI) are a problem for postmenopausal women. The aim of this trial is to evaluate the effectiveness of lactobacilli in combination with low dose estriol for preventing recurrent urinary tract infections in postmenopausal women. |
| Detailed Description | Not Provided |
| Study Type ICMJE | Interventional |
| Study Phase | Phase 4 |
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Condition ICMJE | Urinary Tract Infections |
| Intervention ICMJE | Drug: Gynoflor E (low dose estriol with lactobacillus)
The medication, in the form of one vaginal tablet, is administered in the evenings for 18 days
Other Name: Gynoflor E vaginal tablet |
| Study Arm (s) |
|
| Publications * | Not Provided |
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Enrolling by invitation |
| Estimated Enrollment ICMJE | 142 |
| Estimated Completion Date | July 2010 |
| Estimated Primary Completion Date | May 2010 (final data collection date for primary outcome measure) |
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Female |
| Ages | 40 Years and older |
| Accepts Healthy Volunteers | No |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | Korea, Republic of |
| Administrative Information | |
| NCT Number ICMJE | NCT00900653 |
| Other Study ID Numbers ICMJE | 4-2009-0022 |
| Has Data Monitoring Committee | No |
| Responsible Party | Jun Yong Choi, Yonsei University College of Medicine |
| Study Sponsor ICMJE | Yonsei University |
| Collaborators ICMJE | Not Provided |
| Investigators ICMJE | Not Provided |
| Information Provided By | Yonsei University |
| Verification Date | May 2009 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|